FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:ST6GALNAC6-PAWR

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: ST6GALNAC6-PAWR
FusionPDB ID: 87010
FusionGDB2.0 ID: 87010
HgeneTgene
Gene symbol

ST6GALNAC6

PAWR

Gene ID

30815

5074

Gene nameST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 6pro-apoptotic WT1 regulator
SynonymsSIAT7-F|SIAT7F|ST6GALNACVIPAR4|Par-4
Cytomap

9q34.11

12q21.2

Type of geneprotein-codingprotein-coding
Descriptionalpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6CMP-NeuAC:(beta)-N-acetylgalactosaminide (alpha)2,6-sialyltransferase member VIST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6ST6 -PRKC apoptosis WT1 regulator proteinPRKC, apoptosis, WT1, regulatorWT1-interacting proteinprostate apoptosis response protein 4prostate apoptosis response protein PAR-4prostate apoptosis response-4transcriptional repressor PAR4
Modification date2020032020200313
UniProtAcc..
Ensembl transtripts involved in fusion geneENST idsENST00000291839, ENST00000373141, 
ENST00000373142, ENST00000373144, 
ENST00000373146, ENST00000542456, 
ENST00000485320, 
ENST00000547571, 
ENST00000328827, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score3 X 3 X 2=1814 X 10 X 7=980
# samples 216
** MAII scorelog2(2/18*10)=0.15200309344505
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
log2(16/980*10)=-2.61470984411521
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: ST6GALNAC6 [Title/Abstract] AND PAWR [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: ST6GALNAC6 [Title/Abstract] AND PAWR [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)ST6GALNAC6(130656791)-PAWR(79990438), # samples:2
Anticipated loss of major functional domain due to fusion event.ST6GALNAC6-PAWR seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ST6GALNAC6-PAWR seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ST6GALNAC6-PAWR seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
ST6GALNAC6-PAWR seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
ST6GALNAC6-PAWR seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneST6GALNAC6

GO:0006677

glycosylceramide metabolic process

17123352

HgeneST6GALNAC6

GO:0006687

glycosphingolipid metabolic process

17123352

HgeneST6GALNAC6

GO:0009100

glycoprotein metabolic process

17123352



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr9:130656791/chr12:79990438)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across ST6GALNAC6 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across PAWR (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000373146ST6GALNAC6chr9130656791-ENST00000328827PAWRchr1279990438-8550477328816162
ENST00000373142ST6GALNAC6chr9130656791-ENST00000328827PAWRchr1279990438-8543470321809162

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000373146ENST00000328827ST6GALNAC6chr9130656791-PAWRchr1279990438-0.0020247540.9979753
ENST00000373142ENST00000328827ST6GALNAC6chr9130656791-PAWRchr1279990438-0.0020315590.9979684

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for ST6GALNAC6-PAWR

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
ST6GALNAC6chr9130656791PAWRchr127999043847049GASLTAMSPFSATSTTSVSEEDVSSR
ST6GALNAC6chr9130656791PAWRchr127999043847749GASLTAMSPFSATSTTSVSEEDVSSR

Top

Potential FusionNeoAntigen Information of ST6GALNAC6-PAWR in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ST6GALNAC6-PAWR_130656791_79990438.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-A02:21FSATSTTSV0.96130.7351918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C04:06FSATSTTSV0.99960.9023918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C15:06FSATSTTSV0.99960.9489918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C15:04FSATSTTSV0.99940.9407918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C03:07FSATSTTSV0.99940.9852918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C05:09FSATSTTSV0.99880.9705918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C03:19FSATSTTSV0.99830.9928918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C12:04FSATSTTSV0.9980.9946918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C08:13FSATSTTSV0.99790.9716918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C08:04FSATSTTSV0.99790.9716918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C06:03FSATSTTSV0.99760.995918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C03:08FSATSTTSV0.9960.9315918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C08:15FSATSTTSV0.99230.9832918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C08:03FSATSTTSV0.99110.9889918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C12:12FSATSTTSV0.99110.948918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C01:17FSATSTTSV0.99050.9509918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-A02:05FSATSTTSV0.98280.5117918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C02:06FSATSTTSV0.9450.9793918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-B07:12SPFSATSTT0.7990.5785716
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C01:30FSATSTTSV0.77970.9694918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C03:14FSATSTTSV0.74530.983918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-B39:10SPFSATSTT0.2390.9535716
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-B07:12SPFSATSTTSV0.99790.6411718
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-B78:01SPFSATSTTSV0.98490.5213718
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-B42:01SPFSATSTTSV0.96440.7377718
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-B39:10SPFSATSTTSV0.91480.9543718
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C15:05FSATSTTSV0.99970.9287918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C15:02FSATSTTSV0.99970.9215918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C15:09FSATSTTSV0.99940.9407918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C05:01FSATSTTSV0.99880.9705918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C04:03FSATSTTSV0.99880.8326918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C03:17FSATSTTSV0.99860.9708918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C03:05FSATSTTSV0.99860.937918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C16:04FSATSTTSV0.99640.9843918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-A68:02FSATSTTSV0.99570.8067918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C12:03FSATSTTSV0.99560.983918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C01:03FSATSTTSV0.99460.9498918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C03:04FSATSTTSV0.99460.9918918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C03:03FSATSTTSV0.99460.9918918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C03:06FSATSTTSV0.99460.9916918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-A69:01FSATSTTSV0.99320.7519918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C08:02FSATSTTSV0.99230.9832918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C03:02FSATSTTSV0.9920.974918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C08:01FSATSTTSV0.99110.9889918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C01:02FSATSTTSV0.99090.9487918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C16:02FSATSTTSV0.98660.9907918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C12:02FSATSTTSV0.98370.9764918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-A02:14FSATSTTSV0.96190.6617918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-A02:06FSATSTTSV0.96130.7351918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C16:01FSATSTTSV0.95860.9805918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C02:10FSATSTTSV0.91910.9829918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C02:02FSATSTTSV0.91910.9829918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C17:01FSATSTTSV0.84730.9595918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-C07:04FSATSTTSV0.76610.948918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-B07:13FSATSTTSV0.49150.8528918
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-B67:01SPFSATSTT0.43510.8768716
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-B55:04SPFSATSTTSV0.9920.5735718
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-B78:02SPFSATSTTSV0.98470.5713718
ST6GALNAC6-PAWRchr9130656791chr1279990438470HLA-B67:01SPFSATSTTSV0.94390.8964718

Top

Potential FusionNeoAntigen Information of ST6GALNAC6-PAWR in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ST6GALNAC6-PAWR_130656791_79990438.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0102GASLTAMSPFSATST015
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0123GASLTAMSPFSATST015
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0469MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0469AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0469SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0469TAMSPFSATSTTSVS419
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0701MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0701AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0701SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0701TAMSPFSATSTTSVS419
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0703MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0703AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0703SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0703TAMSPFSATSTTSVS419
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0704MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0704AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0705MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0705AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0705SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0705TAMSPFSATSTTSVS419
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0706MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0706AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0706SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0706TAMSPFSATSTTSVS419
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0707MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0707AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0707SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0707TAMSPFSATSTTSVS419
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0708MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0708AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0708SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0708TAMSPFSATSTTSVS419
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0709MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0709AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0709SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0709TAMSPFSATSTTSVS419
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0711MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0711AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0711SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0712MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0712AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0712SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0712TAMSPFSATSTTSVS419
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0713MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0713AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0713SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0713TAMSPFSATSTTSVS419
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0714MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0714AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0714SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0714TAMSPFSATSTTSVS419
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0715MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0715AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0715SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0715TAMSPFSATSTTSVS419
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0716MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0716AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0716SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0716TAMSPFSATSTTSVS419
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0717MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0717AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0717SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0717TAMSPFSATSTTSVS419
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0719MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0719AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0719SPFSATSTTSVSEED722
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0719TAMSPFSATSTTSVS419
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0901MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0903MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0904MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0904AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0905MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0907MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0907AMSPFSATSTTSVSE520
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-0909MSPFSATSTTSVSEE621
ST6GALNAC6-PAWRchr9130656791chr1279990438470DRB1-1002GASLTAMSPFSATST015

Top

Fusion breakpoint peptide structures of ST6GALNAC6-PAWR

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
6017MSPFSATSTTSVSEST6GALNAC6PAWRchr9130656791chr1279990438470

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of ST6GALNAC6-PAWR

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN6017MSPFSATSTTSVSE-7.9962-8.1096
HLA-B14:023BVN6017MSPFSATSTTSVSE-5.70842-6.74372
HLA-B52:013W396017MSPFSATSTTSVSE-6.83737-6.95077
HLA-B52:013W396017MSPFSATSTTSVSE-4.4836-5.5189
HLA-A11:014UQ26017MSPFSATSTTSVSE-10.0067-10.1201
HLA-A11:014UQ26017MSPFSATSTTSVSE-9.03915-10.0745
HLA-A24:025HGA6017MSPFSATSTTSVSE-6.56204-6.67544
HLA-A24:025HGA6017MSPFSATSTTSVSE-5.42271-6.45801
HLA-B44:053DX86017MSPFSATSTTSVSE-7.85648-8.89178
HLA-B44:053DX86017MSPFSATSTTSVSE-5.3978-5.5112
HLA-A02:016TDR6017MSPFSATSTTSVSE-3.37154-4.40684

Top

Vaccine Design for the FusionNeoAntigens of ST6GALNAC6-PAWR

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
ST6GALNAC6-PAWRchr9130656791chr1279990438716SPFSATSTTCCCATTCTCGGCAACAAGCACAACCAG
ST6GALNAC6-PAWRchr9130656791chr1279990438718SPFSATSTTSVCCCATTCTCGGCAACAAGCACAACCAGTGTCTC
ST6GALNAC6-PAWRchr9130656791chr1279990438918FSATSTTSVCTCGGCAACAAGCACAACCAGTGTCTC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
ST6GALNAC6-PAWRchr9130656791chr1279990438015GASLTAMSPFSATSTAGCATCACTGACGGCTATGTCCCCATTCTCGGCAACAAGCACAAC
ST6GALNAC6-PAWRchr9130656791chr1279990438419TAMSPFSATSTTSVSGGCTATGTCCCCATTCTCGGCAACAAGCACAACCAGTGTCTCTGA
ST6GALNAC6-PAWRchr9130656791chr1279990438520AMSPFSATSTTSVSETATGTCCCCATTCTCGGCAACAAGCACAACCAGTGTCTCTGAAGA
ST6GALNAC6-PAWRchr9130656791chr1279990438621MSPFSATSTTSVSEEGTCCCCATTCTCGGCAACAAGCACAACCAGTGTCTCTGAAGAAGA
ST6GALNAC6-PAWRchr9130656791chr1279990438722SPFSATSTTSVSEEDCCCATTCTCGGCAACAAGCACAACCAGTGTCTCTGAAGAAGATGT

Top

Information of the samples that have these potential fusion neoantigens of ST6GALNAC6-PAWR

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
SARCST6GALNAC6-PAWRchr9130656791ENST00000373142chr1279990438ENST00000328827TCGA-DX-A3M1-01A

Top

Potential target of CAR-T therapy development for ST6GALNAC6-PAWR

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneST6GALNAC6chr9:130656791chr12:79990438ENST00000291839-3644_6499334.0TransmembraneHelical%3B Signal-anchor for type II membrane protein
HgeneST6GALNAC6chr9:130656791chr12:79990438ENST00000373141-3644_6465300.0TransmembraneHelical%3B Signal-anchor for type II membrane protein
HgeneST6GALNAC6chr9:130656791chr12:79990438ENST00000373142-4744_6499375.0TransmembraneHelical%3B Signal-anchor for type II membrane protein
HgeneST6GALNAC6chr9:130656791chr12:79990438ENST00000373144-3644_6465300.0TransmembraneHelical%3B Signal-anchor for type II membrane protein
HgeneST6GALNAC6chr9:130656791chr12:79990438ENST00000373146-4744_6499334.0TransmembraneHelical%3B Signal-anchor for type II membrane protein

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to ST6GALNAC6-PAWR

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to ST6GALNAC6-PAWR

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource